arrow_back Back to App

Drug Price Transparency: Rebates Must Go Directly to Patients at Sale

This law changes rules for prescription drug rebates in Medicare and private health insurance plans. Its primary goal is to ensure that all discounts negotiated by middlemen (PBMs) are immediately passed on to patients at the point of sale. This aims to reduce the out-of-pocket costs citizens pay directly at the pharmacy counter.
Key points
All drug discounts must now be reflected directly in the price at the pharmacy counter, immediately lowering the cost for the patient.
These rules apply to both federal insurance programs (Medicare) and all private health plans.
Compensation for Pharmacy Benefit Managers (PBMs) must shift to transparent, flat service fees, eliminating incentives tied to drug list prices.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_1131
Sponsor: Sen. Braun, Mike [R-IN]
Process start date: 2023-03-30